Thus, in order to provide insight into the impact of the IFNL4 SNPs in SARS-CoV-2 infections, we investigated whether genotypes of rs11322783 SNP were differently distributed between patients with COVID-19 and the European validated group of healthy controls [31]. This evidence concerns the gene IFNL4 and COVID-19.